MRNA vs PANW

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 01, 2026

MRNA

57.3
AI Score
VS
PANW Wins

PANW

62.0
AI Score

Investment Advisor Scores

MRNA

57score
Recommendation
HOLD

PANW

62score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric MRNA PANW Winner
Forward P/E 23.0415 74.6269 MRNA
PEG Ratio 0 4.9645 Tie
Revenue Growth 260.2% 31.1% MRNA
Earnings Growth -85.1% 60.5% PANW
Tradestie Score 57.3/100 62.0/100 PANW
Profit Margin -143.6% 8.0% PANW
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY PANW

Frequently Asked Questions

Based on our detailed analysis, PANW is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.